Long-Term Metformin Usage and Cognitive Function among Older Adults with Diabetes
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Evidence strongly supports the important role of insulin resistance in cognitive decline and dementia and suggests that insulin sensitizers may protect against cognitive decline in diabetic and pre-diabetic individuals. Inconclusive results have been reported in clinical trials of rosiglitazone, an insulin sensitizer that also increases cardiovascular mortality risks. No study has yet reported a protective cognitive effect of metformin, an insulin-sensitizing biguanide widely used in diabetic patients. We studied 365 older persons aged 55 and over in the population-based Singapore Longitudinal Aging Study with diabetes who were followed up over 4 years. The odds ratios (OR) of association of metformin use (n = 204) versus non-use (n = 161) with cognitive impairment (Mini-Mental State Exam ≤ 23), and by duration: up to 6 years (n = 114) and more than 6 years (n = 90) were evaluated in cross-sectional and longitudinal multivariate analyses. Controlling for age, education, diabetes duration, fasting blood glucose, vascular and non-vascular risk factors, metformin use showed a significant inverse association with cognitive impairment in longitudinal analysis (OR = 0.49, 95% CI 0.25-0.95). Metformin use showed significant linear trends of association across duration of use in cross-sectional and longitudinal analyses (p = 0.018 and p = 0.002, respectively), with use for more than 6 years significantly associated with lowest risk of cognitive impairment in both cross-sectional anal…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304]”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [304]
In the citing paper
“In the Singapore Longitudinal Aging Study 2,365 subjects with diabetes (age ≥ 55) were monitored for 4 years – see Table 2 (116). In a cross-sectional and longitudinal multivariate analysis, odds ratios of association of the chronic use of metformin with cognitive disability (Mini-Mental State Exam ≤ 23) were evaluated demonstrating a substantial inverse relationship with cognitive impairment (116”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [116]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · cited 2×
“Metformin has also been shown to attenuate inflammation in experimental models of central inflammation by modulating proinflammatory responses in rat primary microglia cells through both AMPK-dependent and AMPK-independent mechanisms [36].”
BackgroundAppendix G: Geriatric Depression Scale
(2015) · Deep Brain Stimulation Management · doi:10.1017/cbo9781316026625.021 · Cited by 1,536
Farris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies
Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207
Kirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“This is responsible for the known effects of metformin in inhibiting hepatic glucose production, increasing insulin sensitivity, enhancing peripheral utilization of glucose (from improved insulin binding to insulin receptors), and increasing fatty acid oxidation [31], leading to improved glycemic and lipid profiles fr…”
BackgroundCognitive decline and dementia in diabetes—systematic overview of prospective observational studies
Cukierman, T., Gerstein, H. C., & Williamson, J. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0023-4 · Cited by 1,049
Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686
Watson, G. S. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 597
Cited by
Metformin as a tool to target aging
Barzilai, N., Crandall, J. P., Kritchevsky, S. B., & Espeland, M. A. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.011 · Cited by 1,096
Aging and age‐related diseases: from mechanisms to therapeutic strategies
Li, Z., Zhang, Z., Ren, Y., Wang, Y., Fang, J., Yue, H., Ma, S., & Guan, F. (2021) · Biogerontology · doi:10.1007/s10522-021-09910-5 · Cited by 640
Interventions to slow aging in humans: are we ready?
Longo, V. D., Antebi, A., Bartke, A., Barzilai, N., Brown‐Borg, H. M., Caruso, C., Curiel, T. J., Cabo, R., Franceschi, C., Gems, D., et al. (2015) · Aging Cell · doi:10.1111/acel.12338 · Cited by 592
“, 2014), and possibly cognitive decline (Ng et al., 2014).”
Campbell, J. M., Bellman, S. M., Stephenson, M. D., & Lisy., K. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.08.003 · Cited by 455
Ageing, Cellular Senescence and Neurodegenerative Disease
Kritsilis, M., V. Rizou, S., Koutsoudaki, P. N., Evangelou, K., Gorgoulis, V. G., & Papadopoulos, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102937 · Cited by 448
“For example, although some epidemiological studies supported a protective role for metformin, which crosses the BBB, in preventing cognitive decline in individuals with type 2 diabetes [304], another 12-year cohort study in patients with type 2 diabetes showed a two-fold increase in the risk of AD and PD in those who…”
ResultGlucose regulation, cognition, and brain MRI in type 2 diabetes: a systematic review
Geijselaers, S. L. C., Sep, S. J. S., Stehouwer, C. D. A., & Biessels, G. J. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70148-2 · Cited by 377
Justice, J. N., Ferrucci, L., Newman, A. B., Aroda, V. R., Bahnson, J. L., Divers, J., Espeland, M. A., Marcovina, S., Pollak, M. N., Kritchevsky, S. B., et al. (2018) · GeroScience · doi:10.1007/s11357-018-0042-y · Cited by 359
de la Monte, S. M. (2017) · Drugs · doi:10.1007/s40265-016-0674-0 · Cited by 331
Metformin: a review of its potential indications
Wang, Y.-W., He, S.-J., Feng, X., Cheng, J., Luo, Y.-T., Tian, L., & Huang, Q. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s141675 · Cited by 320
The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 304
Campbell, J. M., Stephenson, M. D., de Courten, B., Chapman, I., Bellman, S. M., & Aromataris, E. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180263 · Cited by 292
Mohammed, I., Hollenberg, M. D., Ding, H., & Triggle, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.718942 · Cited by 278
Metformin: Is it a drug for all reasons and diseases?
Triggle, C. R., Mohammed, I., Bshesh, K., Marei, I., Ye, K., Ding, H., MacDonald, R., Hollenberg, M. D., & Hill, M. A. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155223 · Cited by 275
Markowicz-Piasecka, M., Sikora, J., Szydłowska, A., Skupień, A., Mikiciuk-Olasik, E., & Huttunen, K. M. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2199-y · Cited by 257
Tumminia, A., Vinciguerra, F., Parisi, M., & Frittitta, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113306 · Cited by 249
Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes
Dutta, S., Shah, R. B., Singhal, S., Dutta, S. B., Bansal, S., Sinha, S., & Haque, M. (2023) · Drug Design, Development and Therapy · doi:10.2147/dddt.s409373 · Cited by 248
Human trials exploring anti-aging medicines
Guarente, L., Sinclair, D. A., & Kroemer, G. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.007 · Cited by 244
Obesity and aging: Molecular mechanisms and therapeutic approaches
Santos, A. L., & Sinha, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101268 · Cited by 230
Guo, M., Mi, J., Jiang, Q., Xu, J., Tang, Y., Tian, G., & Wang, B. (2014) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12265 · Cited by 225
Neurogenesis in aging and age-related neurodegenerative diseases
Culig, L., Chu, X., & Bohr, V. A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101636 · Cited by 218
Senolytics and senostatics as adjuvant tumour therapy
Short, S., Fielder, E., Miwa, S., & von Zglinicki, T. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.01.056 · Cited by 202
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Baker, C., Retzik-Stahr, C., Singh, V., Plomondon, R., Anderson, V., & Rasouli, N. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018820980225 · Cited by 181
Metformin: A Hopeful Promise in Aging Research
Novelle, M. G., Ali, A., Diéguez, C., Bernier, M., & de Cabo, R. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025932 · Cited by 178
Wahl, D., Solon-Biet, S. M., Cogger, V. C., Fontana, L., Simpson, S. J., Le Couteur, D. G., & Ribeiro, R. V. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104481 · Cited by 144
Xu, X., Sun, Y., Cen, X., Shan, B., Zhao, Q., Xie, T., Wang, Z., Hou, T., Xue, Y., Zhang, M., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00858-3 · Cited by 171
Type 2 Diabetes, Cognition, and Dementia in Older Adults: Toward a Precision Health Approach
Cholerton, B., Baker, L. D., Montine, T. J., & Craft, S. (2016) · Diabetes Spectrum · doi:10.2337/ds16-0041 · Cited by 170
Sato, N., & Morishita, R. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00199 · Cited by 163
Kodali, M., Attaluri, S., Madhu, L. N., Shuai, B., Upadhya, R., Gonzalez, J. J., Rao, X., & Shetty, A. K. (2021) · Aging Cell · doi:10.1111/acel.13277 · Cited by 163
Diabetes and ageing‐induced vascular inflammation
Assar, M. E., Angulo, J., & Rodríguez‐Mañas, L. (2015) · The Journal of Physiology · doi:10.1113/jp270841 · Cited by 150
Shi, Q., Liu, S., Fonseca, V. A., Thethi, T. K., & Shi, L. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024954 · Cited by 144
Metformin and ageing: improving ageing outcomes beyond glycaemic control
Valencia, W. M., Palacio, A., Tamariz, L., & Florez, H. (2017) · Diabetologia · doi:10.1007/s00125-017-4349-5 · Cited by 142
Stanciu, G. D., Bild, V., Ababei, D. C., Rusu, R.-N., Cobzaru, A., Păduraru, L., & Bulea, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061713 · Cited by 140
Amin, S., Lux, A. L., & O'Callaghan, F. J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13780 · Cited by 137
Chen, J., Luo, C., Pu, D., Zhang, G., Zhao, Y., Sun, Y., Zhao, K., Liao, Z., Lv, A., Zhu, S., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.09.008 · Cited by 136
Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer’s Disease
Hölscher, C. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00088 · Cited by 129
Bidirectional interactions between diabetes and Alzheimer's disease
Shinohara, M., & Sato, N. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.04.020 · Cited by 127
Nutritional strategies to optimise cognitive function in the aging brain
Wahl, D., Cogger, V. C., Solon‐Biet, S. M., Waern, R. V. R., Gokarn, R., Pulpitel, T., de Cabo, R., Mattson, M. P., Raubenheimer, D., Simpson, S. J., et al. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.06.006 · Cited by 128
Impact of antidiabetic agents on dementia risk: A Bayesian network meta-analysis
Zhou, J., Tang, X., Han, M., Yang, J., & Simó, R. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154265 · Cited by 128
Weinstein, G., Davis‐Plourde, K. L., Conner, S. C., Himali, J. J., Beiser, A., Lee, A., Rawlings, A. M., Sedaghat, S., Ding, J., Moshier, E. L., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212293 · Cited by 124
Association of Metformin Use With Age-Related Macular Degeneration: A Case-Control Study
Blitzer, A. L., Ham, S. A., Colby, K. A., & Skondra, D. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6331 · Cited by 123
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 120
Zheng, M., & Wang, P. (2021) · 3 Biotech · doi:10.1007/s13205-021-02738-3 · Cited by 118
Metformin as a geroprotector: experimental and clinical evidence
Piskovatska, V., Stefanyshyn, N., Storey, K. B., Vaiserman, A. M., & Lushchak, O. V. (2018) · Biogerontology · doi:10.1007/s10522-018-9773-5 · Cited by 114
Cao, B., Rosenblat, J. D., Brietzke, E. M., Park, C., Lee, Y. L., Musial, N., Pan, Z., Mansur, R. B., & McIntyre, R. S. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13373 · Cited by 110
Sebastião, I., Candeias, E., Santos, M. S., Oliveira, C. R., Moreira, P. I., & Duarte, A. I. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00110 · Cited by 108
Differential metformin dose-dependent effects on cognition in rats: role of Akt
Mostafa, D. K., Ismail, C. A., & Ghareeb, D. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4301-2 · Cited by 108
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
Chin-Hsiao, T. (2019) · Aging and disease · doi:10.14336/ad.2017.1202 · Cited by 98
Ping, F., Jiang, N., & Li, Y. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001370 · Cited by 100
Ala, M., & Ala, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00167 · Cited by 95
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
Metabolic Aspects of Adenosine Functions in the Brain
Garcia‐Gil, M., Camici, M., Allegrini, S., Pesi, R., & Tozzi, M. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.672182 · Cited by 96
Chen, Q., Mo, R., Wu, N., Zou, X., Shi, C., Gong, J., Li, J., Fang, K., Wang, D., De-shen, Y., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00334 · Cited by 96
Ge, X., Zhu, G., Geng, D., Zhang, H.-Z., He, J.-M., Guo, A.-Z., Ma, L.-L., & Yu, D. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.12.021 · Cited by 96
Li, N., Zhou, T. G., & Fei, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158281 · Cited by 94
Metformin: An old drug against old age and associated morbidities
Salvatore, T., Pafundi, P. C., Morgillo, F., Liello, R. D., Galiero, R., Nevola, R., Marfella, R., Monaco, L., Rinaldi, L., Adinolfi, L. E., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108025 · Cited by 91
Associations Between Diabetes Mellitus and Neurodegenerative Diseases
Szablewski, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020542 · Cited by 89
From rapalogs to anti-aging formula
Blagosklonny, M. V. (2017) · Oncotarget · doi:10.18632/oncotarget.18033 · Cited by 88
Kuate Defo, A., Bakula, V., Pisaturo, A., Labos, C., Wing, S. S., & Daskalopoulou, S. S. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15331 · Cited by 75
Franceschi, C., Garagnani, P., Gensous, N., Bacalini, M. G., Conte, M., & Salvioli, S. (2019) · Aging Cell · doi:10.1111/acel.12903 · Cited by 87
Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer’s Disease
McIntosh, E. C., Nation, D. A., & Initiative, A. D. N. (2019) · Diabetes Care · doi:10.2337/dc18-1399 · Cited by 87
Neurodegeneration in type 2 diabetes: Alzheimer's as a case study
Madhusudhanan, J., Suresh, G., & Devanathan, V. (2020) · Brain and Behavior · doi:10.1002/brb3.1577 · Cited by 85
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study
Herath, P. M., Cherbuin, N., Eramudugolla, R., & Anstey, K. J. (2016) · BioMed Research International · doi:10.1155/2016/7208429 · Cited by 87
Roles for osteocalcin in brain signalling: implications in cognition- and motor-related disorders
Shan, C., Ghosh, A., Guo, X., Wang, S., Hou, Y., Li, S., & Liu, J. (2019) · Molecular Brain · doi:10.1186/s13041-019-0444-5 · Cited by 83
Froldi, G. (2024) · Pharmaceuticals · doi:10.3390/ph17040478 · Cited by 83
McMillan, J. M., Mele, B. S., Hogan, D. B., & Leung, A. A. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2018-000563 · Cited by 80
Petrocelli, J. J., McKenzie, A. I., de Hart, N. M. M. P., Reidy, P. T., Mahmassani, Z. S., Keeble, A. R., Kaput, K. L., Wahl, M., Rondina, M. T., Marcus, R. L., et al. (2023) · Aging Cell · doi:10.1111/acel.13936 · Cited by 81
Tanokashira, D., Kurata, E., Fukuokaya, W., Kawabe, K., Kashiwada, M., Takeuchi, H., Nakazato, M., & Taguchi, A. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12436 · Cited by 76
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 74
Tian, S., Jiang, J., Wang, J., Zhang, Z., Miao, Y., Ji, X., & Bi, Y. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3673 · Cited by 79
Morley, J. E., Farr, S. A., & Nguyen, A. D. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.006 · Cited by 79
Cognitive Impairment in Frail Hypertensive Elderly Patients: Role of Hyperglycemia
Mone, P., Gambardella, J., Pansini, A., Donato, A. D., Martinelli, G., Boccalone, E., Matarese, A., Frullone, S., & Santulli, G. (2021) · Cells · doi:10.3390/cells10082115 · Cited by 75
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
Michailidis, M., Tata, D. Α., Μoraitou, D., Kavvadas, D., Karachrysafi, S., Papamitsou, T., Vareltzis, P. K., & Papaliagkas, V. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094641 · Cited by 74
Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Yaribeygi, H., Ashrafizadeh, M., Henney, N. C., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2019.104611 · Cited by 69
Zhang, Q., Li, W., Liu, Z., Zhang, H., Ba, Y., & Zhang, R. (2020) · Medicine · doi:10.1097/md.0000000000019378 · Cited by 73
Kwok, T. C. Y., Lee, J., Ronald, C. W., Wong, S. Y. S., Kung, K., Lam, A. T., Ho, C. S., Lee, V. W. Y., Harrison, J., & LAM, L. C. W. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.10.018 · Cited by 72
Low, S. K., Goh, K. S., Ng, T. P., Ang, S. F., Moh, A. M. C., Wang, J., Ang, K., Subramaniam, T., Sum, C. F., & Lim, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.10.019 · Cited by 70
Self-citationEvidence for altered insulin receptor signaling in Alzheimer's disease
Griffith, C. M., Eid, T., Rose, G. M., & Patrylo, P. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.008 · Cited by 69
Metformin: A Prospective Alternative for the Treatment of Chronic Pain
Baeza‐Flores, G. D. C., Guzmán‐Priego, C. G., Flores, L. I. P., Murbartián, J., Torres‐López, J. E., & Granados‐Soto, V. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.558474 · Cited by 69
Advancements in therapeutic drugs targeting of senescence
Zhu, M., Meng, P., Ling, X., & Zhou, L. (2020) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622320964125 · Cited by 68
Ha, J.-H., Choi, D., Kim, K. J., Cho, S. Y., Kim, H., Kim, K. Y., Koh, Y., Nam, C. M., & Kim, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-03406-5 · Cited by 67
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer’s disease
Zhao, R. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03031-9 · Cited by 66
Metformin Alters Locomotor and Cognitive Function and Brain Metabolism in Normoglycemic Mice
Li, W., Chaudhari, K., Shetty, R. A., Winters, A., Gao, X., Hu, Z., Ge, W., Sumien, N., Forster, M. J., Liu, R., et al. (2019) · Aging and Disease · doi:10.14336/ad.2019.0120 · Cited by 66
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes
Palleria, C., Leporini, C., Maida, F., Succurro, E., Sarro, G. D., Arturi, F., & Russo, E. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.07.002 · Cited by 65
de la Monte, S. M., Tong, M., Daiello, L. A., & Ott, B. R. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad-180906 · Cited by 56
Health Benefits of Anti-aging Drugs
Piskovatska, V., Strilbytska, O. M., Koliada, A. K., Vaiserman, A. M., & Lushchak, O. V. (2019) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-13-3681-2_13 · Cited by 64
Chen, F., Wei, G., Wang, Y., Liu, T., Huang, T., Wei, Q., Ma, G., & Wang, D. (2019) · BMC Public Health · doi:10.1186/s12889-019-7392-y · Cited by 62
Effects of pioglitazone on the incidence of dementia in patients with diabetes
Chou, P., Ho, B., & Yang, Y. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.01.006 · Cited by 61
The Use of Metformin to Increase the Human Healthspan
Piskovatska, V., Storey, K. B., Vaiserman, A. M., & Lushchak, O. V. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-42667-5_13 · Cited by 60
Involvement of insulin receptor substrates in cognitive impairment and Alzheimer’s disease
Taguchi, A., Tanokashira, D., & Fukuokaya, W. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.253535 · Cited by 59
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58
Gastrointestinal Dysfunction in Parkinson’s Disease: Current and Potential Therapeutics
Han, M. N., Finkelstein, D. I., McQuade, R. M., & Diwakarla, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020144 · Cited by 58
Low, S., Goh, K. S., Ng, T. P., Moh, A., Ang, S. F., Wang, J., Ang, K., Tang, W. E., Lim, Z., Subramaniam, T., et al. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215678 · Cited by 57
Self-citationGeroprotectors: A role in the treatment of frailty
Trendelenburg, A., Scheuren, A. C., Potter, P. K., Müller, R., & Bellantuono, I. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.03.002 · Cited by 54
Diabetes and cognitive decline: Challenges and future direction
Hamid, N. A., Omar, N., Ismail, C. A. N., & Long, I. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i6.795 · Cited by 52
NutrimiRAging: Micromanaging Nutrient Sensing Pathways through Nutrition to Promote Healthy Aging
Micó, V., Berninches, L., Tapia, J., & Daimiel, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050915 · Cited by 52
Oral diabetes medication and risk of dementia in elderly patients with type 2 diabetes
Kim, J. Y., Ku, Y. S., Kim, H. J., Trinh, N. T., Kim, W., Jeong, B., Heo, T. Y., Lee, M. K., & Lee, K. E. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.07.004 · Cited by 44
Diabetes–Alzheimer's Disease Link: Targeting Mitochondrial Dysfunction and Redox Imbalance
Carvalho, C., & Cardoso, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8056 · Cited by 50
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
Sportelli, C., Urso, D., Jenner, P. G., & Chaudhuri, К. R. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00556 · Cited by 50
Bakhtyukov, A. A., Derkach, K. V., Sorokoumov, V. N., Stepochkina, A. M., Romanova, I. V., Morina, I. Y., Zakharova, I. O., Bayunova, L. V., & Shpakov, A. O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010198 · Cited by 50
Zhang, J., Zhang, X., Sun, Y., Lv, R.-H., Chen, M., & Li, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.984559 · Cited by 50
Metadata
- Authors
- Ng, T. P., Feng, L., Yap, K. B., Lee, T. S., Tan, C. H., & Winblad, B.
- Affiliations
- National University of Singapore (SG)
- Karolinska Institutet (SE)
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2014-06-04
- Volume
- 41
- Issue
- 1
- Pages
- 61-68
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1597817261
- Cited by
- 334
- References
- 35
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 36 · 2023: 33 · 2022: 35 · 2021: 39 · 2020: 42 · 2019: 41 · 2018: 23 · 2017: 14 · 2016: 19 · 2015: 12 · 2014: 6
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- metformin, cognitive impairment
- MeSH terms
- Aged, Aged, 80 and over, Cognition Disorders, Cross-Sectional Studies, Diabetes Mellitus, Female, Humans, Hypoglycemic Agents, Longitudinal Studies, Male, Metformin, Middle Aged, Prospective Studies, Singapore, Time Factors, Multivariate Analysis, Linear Models, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.